Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram after venlafaxine non-response in treatment-resistant major depression
ACTRN12613000256774Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 4, open-label trial of escitalopram and venlafaxine in treatment-resistant depression (TRD) and major depressive disorder (MDD) (2 arms), sponsored by Lundbeck. Started Jan 2005; status: completed.
02
Drugs
escitalopramvenlafaxine
03
Conditions
treatment-resistant depression (TRD)major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12613000256774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000256774.